TY - JOUR
KW - Infectious Diseases
KW - Microbiology (medical)
KW - General Medicine
AU - Sangare M
AU - Berthe A
AU - Dolo H
AU - Diabaté AF
AU - Konipo FDN
AU - Soumaoro L
AU - Doumbia SS
AU - Coulibaly ME
AU - Diarra L
AU - Sanogo Y
AU - Atsou KM
AU - Diallo AA
AU - Coulibaly SY
AU - Keita M
AU - Doumbia S
AU - Coulibaly YI
AB - Background<br>
Mali has implemented mass drug administration (MDA) since 2004 aimed to control schistosomiasis and soil-transmitted helminths. Despite several round of MDA, the health district of Bankass reported low coverage (64.8%) for praziquantel and albendazole in 2017 meaning this district is still facing challenges to accomplish the targeted 75% coverage. We aimed to explore the barriers and gaps that hinder the MDA implementation in Bankass.<br>

<br>Methods<br>
We did a cross-sectional study. Questionnaires were administrated to all school-aged children in randomly selected villages. Technical directors of community health centers and community drug distributors in the selected villages were included in the interviews.<br>

<br>Results<br>
We interviewed 2128 children and 52 health workers. Coverage rates were 93.51% (1990/2128) for praziquantel and 95.25% (2027/2128) for albendazole. Among the untreated children, 31.63% (31/98) reported not being aware of the campaign and 26.53% (26/98) were unable to reach the distribution points. Most of the health workers suggested to increase incentives.<br>

<br>Conclusion<br>
Our data shows satisfactory coverage above 90% in contrast with lower rates initially reported by the district health information system. These results raise concerns about the reliability of programmatic data and highlight the importance population-based surveys for the evaluation of control interventions.
BT - International Journal of Infectious Diseases
DO - 10.1016/j.ijid.2021.08.063
LA - eng
N2 - Background<br>
Mali has implemented mass drug administration (MDA) since 2004 aimed to control schistosomiasis and soil-transmitted helminths. Despite several round of MDA, the health district of Bankass reported low coverage (64.8%) for praziquantel and albendazole in 2017 meaning this district is still facing challenges to accomplish the targeted 75% coverage. We aimed to explore the barriers and gaps that hinder the MDA implementation in Bankass.<br>

<br>Methods<br>
We did a cross-sectional study. Questionnaires were administrated to all school-aged children in randomly selected villages. Technical directors of community health centers and community drug distributors in the selected villages were included in the interviews.<br>

<br>Results<br>
We interviewed 2128 children and 52 health workers. Coverage rates were 93.51% (1990/2128) for praziquantel and 95.25% (2027/2128) for albendazole. Among the untreated children, 31.63% (31/98) reported not being aware of the campaign and 26.53% (26/98) were unable to reach the distribution points. Most of the health workers suggested to increase incentives.<br>

<br>Conclusion<br>
Our data shows satisfactory coverage above 90% in contrast with lower rates initially reported by the district health information system. These results raise concerns about the reliability of programmatic data and highlight the importance population-based surveys for the evaluation of control interventions.
PB - Elsevier BV
PY - 2021
T2 - International Journal of Infectious Diseases
TI - Evaluation of mass drug administration for schistosomiasis and soil-transmitted helminths in school-aged children in Bankass, Mali
UR - https://www.sciencedirect.com/science/article/pii/S1201971221006950/pdfft?md5=9268f3aacf4f682a5657153bc6bc81a4&pid=1-s2.0-S1201971221006950-main.pdf
SN - 1201-9712
ER -